ATH alterity therapeutics limited

Ann: Prana provides regulatory update for PBT2-PBT.AX, page-3

  1. 7,425 Posts.
    lightbulb Created with Sketch. 125
    Europe - finally! ...here we come....they wasted 2 years preparing submission to FDA without doing anything to get into Europe....but now with more delays in USA and with FDA demanding more safety trials we are finally going to target different markets...if Europe is a success, they may even start thinking of Asia and rest of the world.....glad something is happening at long last!

    Can someone please ask during AGM what is happening with our development for treatment of Parkinsonian diseases? and what kind of test FDA requested for lifting PCH? My guess is, whatever Prana presented was not good enough....will they require more tests on dogs? rats? or other animal species?..? anything BUT humans?....
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.6¢
Change
0.001(6.67%)
Mkt cap ! $147.3M
Open High Low Value Volume
1.5¢ 1.7¢ 1.5¢ $770.2K 49.71M

Buyers (Bids)

No. Vol. Price($)
8 2038332 1.5¢
 

Sellers (Offers)

Price($) Vol. No.
1.6¢ 349000 2
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.